View post tag: News by topic View post tag: Navy Share this article View post tag: key View post tag: two January 23, 2013 Back to overview,Home naval-today UK: RN Reservists Assume Key Roles in Two International Exercises View post tag: International View post tag: Roles View post tag: Naval View post tag: UK View post tag: Assume View post tag: Reservists UK: RN Reservists Assume Key Roles in Two International Exercises View post tag: Exercises View post tag: RN Royal Naval Reservists from HMS President in London played key roles in two large international exercises in the closing months of 2012.Lieutenant Commanders Howie San and Pat Shinner swapped their civilian careers, the former with US shipping giant AT&T and the latter for a financial software firm in the City of London, and donned their naval uniforms for Exercise Joint Warrior in the northern waters of the UK.At the same time Lieutenant Tony Scott, global enterprise architect for engineering consulting firm Arup, deployed to the Mediterranean with the French Navy in the waters off Toulon and Marseille for Exercise Noble Mariner.As the Submarine Control Team reporting to the Joint Warrior Task Group Commander, Howie and Pat worked in the operations room of the Type 23 frigate HMS Kent.They were responsible for directing the Norwegian submarine HNoMS Utvaer as she engaged warships from a dozen nations in the cat-and-mouse style manoeuvres that define submarine warfare.With 22 warships from a dozen nations taking part in the exercise, the Ula class diesel-electric powered submarine was much in demand. Howie and Pat ensured that her movements did not conflict with that of other submarines operating in the area, including a very special arrival.A day before starting Joint Warrior, HMS Kent was assigned as the safety ship to oversee the first open water dive of the Royal Navy’s newest nuclear submarine, HMS Ambush.Howie said:“It was a privilege to see the latest addition to the Fleet and one of the most powerful submarines in the world.”1,200 miles away, in the warmer Mediterranean waters, Lieutenant Tony Scott was one of a number of personnel from HMS President and other Royal Naval Reserve units who deployed for Exercise Noble Mariner.The annual exercise plays an important part in the certification process of the NATO Response Force (NRF).The objective of Noble Mariner 12 was to certify the capacity of France to lead the maritime component of the NRF. Units taking part included 26 warships from 10 NATO nations, as well as helicopters, Maritime Patrol Aircraft and jet fighters from French Aircraft Carrier Charles de Gaulle.Tony was based on board French Ship Var, a Durance class replenishment tanker equipped with headquarters facilities. He worked as a battle watch captain in the mine warfare battle staff, responsible for the conduct of mine hunting ships and divers from a number of nations.This was the role he performed while mobilised to the Gulf for most of 2009.“Although French-led, our battle staff in Var included representatives from ten NATO countries,” Tony explained.“We all spoke English – mostly – and I was incredibly impressed with how well integrated we became in no time at all.”France only recently re-joined NATO as a full member. This exercise played an important role for the French personnel taking part to gain familiarity in working with their NATO allies.Tony said: “I was pleased to be able to make a difference during the exercise, training French personnel in modern NATO mine warfare practices.“It was a vindication of the training the RNR has given me. But it wasn’t all one-way learning.“For example I spent one day of the exercise in FS Pegase, a French mine hunter, and found some of their capabilities to be very impressive indeed.”Exercises like Joint Warrior and Noble Mariner are just some of the opportunities Royal Naval Reservists have to train alongside their regular counterparts during their annual training fortnights. This training helps prepare them for their longer periods of mobilisation.[mappress]Naval Today Staff, January 23, 2013; Image: Royal Navy Training & Education
Death rates from heroin overdose nearly quadrupled in the United States between 2002 and 2013, when the number of people reporting past-year heroin abuse or dependence rose to 517,000, a nearly 150 percent increase from 2007. In 2014, the use of heroin and other opioids killed 1,256 people in Massachusetts, an increase of 34 percent over 2013 and 88 percent over 2012.The Gazette sought insights across several disciplines for a three-part report on the crisis and new ideas for fighting it. Read the first part, on the science of addiction, here. Read the second part, on policy responses, here.For many, Nalan Ward’s daily routine might seem unbearably depressing. As the director of Massachusetts General Hospital’s West End Clinic, an outpatient facility focused on drug-use disorders, Ward regularly treats patients caught up in a cycle of addiction.Thirty-five percent of patients who walk through the doors of her clinic are suffering a primary opioid-use disorder. And 70 percent of those patients arrive with another serious medical condition directly related to or worsened by the drug use, such as hepatitis C, endocarditis (an inflammation of the inner layer of the heart), or sepsis.Then there is a whole group of complications closely tied to addiction. Seventy to 85 percent of the clinic’s patients, Ward said, are depressed, anxious, or experiencing post-traumatic stress disorder. Such a range of symptoms often presents a confusing tangle of cause and effect, one that makes addiction particularly hard to treat.“It’s a complicated, sick population with psychosocial needs complicated by unemployment, no stable place to live, legal issues … these are the kind of patients we see,” said Ward.But for the Turkish-born doctor, the work is anything but depressing. Her attitude is “positive,” not “burned out and negative,” she says, and she finds nourishment in the knowledge that her efforts save lives.It wasn’t always so. As a young psychiatric resident at Boston Medical Center, Ward became frustrated struggling to treat “hard-to-engage” patients who landed in the emergency room in the middle of the night suffering from withdrawal.“It’s just a very bad setting to encounter patients with addictions. You are trying to rationalize or figure out what’s going with someone who is totally intoxicated. There is not a lot to offer in an acute-care setting. Those are some of the things that shape residents’ views and feelings about addiction, and they don’t necessarily see the good, see the long-term outcome.”Ward is just one of many people in the Harvard medical community attacking the scourge of addiction as users of heroin and other opioids continue to fill emergency rooms, hospital beds, and treatment centers.From 2011 to 2012 McLean Hospital saw a 10 percent jump in opioid-addicted patients in its detox unit, said Kevin Hill, director of the hospital’s Substance Abuse Consultation Service. The increase came despite a rise in the number of patients turned down for inpatient treatment by insurance companies that preferred outpatient options, he said.Brigham and Women’s Faulkner Hospital has accepted more than 200 patients at a treatment clinic that opened in 2013. More than half of the clinic’s 100 active patients have histories of heroin use. At Brigham and Women’s itself, in six years the rate of opioid-related inpatient consults for addiction has increased from 22 percent to 75 percent, said addiction psychiatrist Joji Suzuki, who works with patients at both hospitals.Suzuki noted that the profile of opioid users has also changed. “Today they are younger, more educated, less likely to have HIV … patients come from all walks of life.”What’s happening locally reflects what’s happening across the state. According to the Massachusetts Department of Public Health, the number of patients admitted to programs contracted by or licensed to the Bureau of Substance Abuse Services who listed heroin as their primary drug rose from 38.2 percent in 2005 to 53.1 percent in 2014.‘The more I work with those who suffer, the more I am encouraged by how people change, their ability to change, and the ways we can help.’Doctors, nurses, and counselors at Harvard-affiliated hospitals and institutes are determined to offer hope, providing inpatient and outpatient care and drug-assisted therapies. Research is regularly shining new light on the best treatment options. And addiction specialists across Harvard are working to integrate medical and psychiatric services, facilitating treatment in primary-care settings, addressing co-existing conditions, and ramping up access to effective medications.There also has been a concerted effort to remove the stigma surrounding substance use. Addiction, experts agree, needs to be considered a chronic disease, not unlike asthma, diabetes, or high blood pressure, and managed the same way, with interventions such as medication and regular monitoring, and an understanding that relapse is often a routine part of recovery. The treatment standard needs to shift from an acute-care model, they argue, to one of long-term recovery management.“We really have to embrace the idea,” said Ward, “that this is a chronic disease.”Assessing the landscapeAddiction specialists agree that opioid-use disorders demand a multilayered approach, with medication, self-help, counseling, and family support all key to sustained recovery. It’s an addiction known to be particularly difficult to treat, with first-year relapse rates surpassing 80 percent, according to some estimates. Clinical trials have shown that medication-assisted therapies, often in combination with other treatments, offer opioid addicts some of the best chances at long-term recovery.For years, two drugs have led the way in helping ease people off their dependence on opioids: methadone and buprenorphine. Both medications mimic the drugs they are meant to overcome by activating opiate receptors in the brain, yet their longer-acting formulas prevent the “high” of a drug such as heroin while helping reduce the cravings and withdrawal symptoms that can trigger relapse.Approved for use by the Food and Drug Administration in 1972, methadone is still considered one of the most effective medications available for opioid addiction. To be eligible for methadone maintenance treatment a patient must have been suffering from opioid addiction for at least a year and must have failed at least one other type of intervention. The drug is strictly controlled: Patients must visit a federally regulated methadone clinic to receive their daily dose. For some, such a structured treatment works well. But for others the demands of the regimen rule it out, often in tandem with a sense of shame.“Methadone is an incredibly effective treatment option, but there continues to be a lot of stigma around its use,” said Sarah Wakeman, medical director for the substance-use disorder initiative at Massachusetts General Hospital. “People call it the liquid handcuffs because you are sort of linked to the clinic. You have to be there every morning, no matter what, rain or sun. It’s hard to go on vacation, it’s hard to build your work schedule around it.”In October 2002, the FDA radically changed the treatment landscape when it approved buprenorphine for opioid addiction. Instead of referring patients to a special clinic, certified doctors could prescribe the drug in their offices, enabling patients to take the medicine on their own. “It put addiction treatment back into the mainstream of medical practice,” said Roger Weiss, chief of McLean’s Division of Alcohol and Drug Abuse and director of the hospital’s alcohol and drug abuse research program.Weiss is well-versed in the effectiveness of buprenorphine. In 2011 he released the findings of the largest study to date on treatment for prescription-opioid dependence. The findings demonstrated both the difficulty of beating an opioid addiction and the promise of buprenorphine.In the study’s first phase, addicts used buprenorphine for four weeks, tapering off the drug, and then received no further medication. The pull of opioids was illustrated by the rate of patients — just 7 percent — who were subsequently successful at staying clean.In the second phase, directed at the relapse population, subjects received 12 weeks of buprenorphine treatment, at the end of which 49 percent, seven times as many, were doing well. During the four-week taper from buprenorphine, half of those patients relapsed. There were more relapses — two-thirds of the remaining group — in the two months after the taper period ended.“It showed the effectiveness, at least in a short-term treatment like this, of staying on medication,” Weiss said.A follow-up study of the same patients showed that 3½ years later, many were coping better than they had in the short term, including those who received no medication and had high relapse rates.“The course of this disorder is not constant,” Weiss said. “People have periods of recovery, then periods of relapse and, over time, a number of people do well, but not everybody. There’s a high relapse rate.”Yet even with research supporting the efficacy of buprenorphine, patients across the country routinely struggle to get it. When the FDA sanctioned the drug 13 years ago, the hope was that doctors would begin prescribing it for appropriate patients in their practices. But few actually have. According to the nonprofit National Alliance of Advocates for Buprenorphine Treatment, only 3 percent of the 800,000 doctors in the United States are certified to prescribe it. In Massachusetts, just 751 doctors authorized to treat opioid addiction with buprenorphine are listed on the website of the federal Substance Abuse and Mental Health Services Administration.“The drug companies are manufacturing it, the treatment exists,” said Wakeman, long a licensed prescriber. “There’s not a drug shortage, there’s a doctor shortage.”One hurdle facing physicians is the added training required for certification. Doctors must take an eight-hour course, pass a test, and then register with the Drug Enforcement Agency, which grants prescription licenses. Doctors in their first year are allowed to treat a maximum of 30 patients and must reapply in order to increase their patient capacity to 100. Insurance is also a factor. Some providers require prior authorizations, set arbitrary dose limits, or even encourage doctors to stop prescribing buprenorphine altogether.One treatment obstacle Mark Albanese of Cambridge Health Alliance occasionally encounters is the idea that medication might replace rather than subdue addiction. Kris Snibbe/Harvard Staff PhotographerEven among the certified, the number of prescriptions for buprenorphine remains low, partly because many doctors simply aren’t comfortable treating addiction.“They don’t feel they know enough about it, and they find it kind of a daunting task,” said Weiss, “and so they just say ‘Let somebody else do it.’ I think that’s really the issue.”Ward agreed.“People get trained to prescribe this medication. They hold a license for it but they don’t necessarily treat patients because they don’t feel comfortable.”Another issue is the idea of total abstinence espoused by many 12-step programs and residential treatment facilities. It’s not unheard of for patients to resist medication regimens. Mark Albanese, the director of Adult Outpatient and Addictions Services at the Cambridge Health Alliance (CHA), said sometimes his patients complain that they feel as hooked on their prescriptions as they had been on heroin. To calm their fears, Albanese offers a little perspective.“I say, ‘Let’s step back for a second. Tell me how much alike your life is now versus what it was when you were actively using heroin?’ And they just laugh at me and say, ‘It’s nothing like that.’”Collaborative thinking One model of care, in place at Brigham and Women’s for years, focuses on treating patients in non-specialized settings.“We still need the specialty addiction clinics for patients who want it, who can access it, but here at the Brigham we focus on offering similar approaches without sending patients somewhere else,” said Suzuki. “We try our best to actually take ownership of it and say, ‘This is a major health issue that’s impacting your health and we’d like to help you.’”When an opioid-addicted patient checks in at the Brigham seeking treatment for anything from a broken leg to pneumonia, a dedicated team, including an addiction physician, a group of addiction fellows, and a social worker, is activated. The group meets with the patient to discuss treatment options and to offer to immediately start him or her on buprenorphine.“Beginning treatment while they are here in the hospital … while it seems like such a small thing, at many hospitals it’s simply not done,” said Suzuki, the team’s attending addiction psychiatrist.Suzuki and his team help connect hospitalized patients with outpatient treatment options and community-support groups, enlist the aid of family and friends, and review relapse-prevention skills. Suzuki also works closely with the Brigham’s primary-care clinics, offering specialized guidance.“We’re not trained; we don’t have any expertise; we don’t have any clinical support; we don’t have enough time; I am afraid of these patients … there’s a long list of barriers that people working in the clinics describe,” he said.Undergraduate health coaches support the clinics. The students, often on a pre-med track, call patients to check on mood, cravings, and pain, as well as to monitor prescriptions and issue appointment reminders. They also relay any concerns they may have about the patient back to the team.For doctors trying to manage their already-stretched time, the support model, said Suzuki, “has a potential of actually making a big difference on a wider scale.”A similar approach is underway at MGH, which is building on early efforts to offer buprenorphine in its community health centers in 2003, soon after the drug received FDA approval.Last year an updated strategic plan in which MGH re-examined its long-range clinical mission made targeting addiction a top priority. In the next three years the hospital will spend $3.5 million on long-term substance-use disorders.The effort calls for collaborations among medical and psychiatric services to enhance addiction care, including a recently formed hospital-based Addiction Consult Team, similar to that at the Brigham. The team consists of psychiatrists, primary-care doctors, nurses, and social workers, and is called when a patient suffering from addiction is identified.“This is a new formal consult service where folks are working together and bringing the best state-of-the-art treatment together for all types of substance-use disorders,” said James Morrill, chief of the Adult Medicine Unit at MGH’s Charlestown HealthCare Center.The team helps connect hospital patients with outpatient services, in part through recovery coaches, ex-users affiliated with one of MGH’s three community health centers. The coaches also work directly in the centers, helping patients with everything from recovery support to how to find housing.Focus on trainingImproving access to treatment includes easing doctors’ interactions with patients fighting substance-abuse disorders. And that engagement has to happen as early as possible.At Harvard Medical School, students first learn about addiction during an introductory psychiatry course in their second year. The class covers the epidemiology, public health impact, and neuroscience of addiction, as well as the range of treatment options and community support available. Students also learn how to interview and screen drug users. During clinical clerkships at Harvard-affiliated hospitals in their third year, HMS students engage directly with patients suffering from opioid addiction in a variety of settings.But among teachers at HMS, which is currently overhauling its curriculum, there is a growing realization that perhaps the best way to help prepare students to treat addiction is to connect them with patients sooner.“One way that the curriculum is moving as part of the HMS curricular reform is toward covering the really important parts of lots of important topics in a shorter period of time pre-clinically, and then getting students involved with patients from the get-go,” said Todd Griswold, a psychiatrist at the Cambridge Health Alliance and the director of medical student education in psychiatry at HMS.Asked if addiction training could be increased for Harvard’s medical students, Griswold said “absolutely,” but with the caveat that so too could training in a range of other areas. “If you add to a particular topic, you have to think about what you are going to remove.”When it comes to prescribing buprenorphine, more doctors and students need to learn how to do it, experts say. At MGH, Ward is making that happen. Together with a group of colleagues she has helped offer training in buprenorphine treatment to doctors across the hospital, positioning them to receive DEA approval. Last month she helped train primary-care residents during an annual retreat that for the first time focused on buprenorphine.Wakeman is also working to sharpen residents’ training. As chief resident at MGH in 2012, she helped develop a survey of internal-medicine residents at the hospital that showed most felt unprepared to diagnose and treat patients suffering from substance-use disorders. In response, MGH boosted the number of lectures on addiction from one a year to 12. Progress was limited. When Wakeman repeated the survey with the new curriculum, the results showed that while residents were significantly more prepared, their knowledge hadn’t increased.“That really gets to the fact that we learn medicine through doing and seeing,” she said.For more hands-on training, internal-medicine residents are beginning to round with MGH’s Addiction Consult Team, and there is a push to have the intensive two-week outpatient rotation in addiction required for primary-care residents extended to all internal-medicine residents.“We are in the middle of a public health crisis,” said Wakeman. “We have treatment that works and yet doctors aren’t providing that treatment, and I think the only way to really change that, change that culture, is to better train the next generation of doctors to feel like this is something that they own, that it’s a part of our skill set and that they have the tools they need.”The other sideIn contrast to those difficult nights in the ER, Ward these days can see further along her patients’ journeys, and can feel the hope they keep close. After years of working with people struggling to get clean, she understands just how incredibly complicated treatment is. She knows addiction is a disease that takes a vise-like hold on users with certain genetic susceptibilities, and that over time it can actually alter the way the brain functions, making “drug-free” seem excruciatingly distant. She also understands the treatment map and the range of effective therapies that can bring addicts back from the edge.Still, even within the medical community, she acknowledges, there are doubters, those who wonder why she spends so much effort on patients who, to many, seem beyond help. They don’t bother her.“It’s an opportunity to educate,” Ward said, “to say, ‘Look, there’s a whole different side to this disease and treatment is not that straightforward, but individuals who suffer from substance-use disorders can be treated.“There is hope in this field,” she emphasized. “Addiction’s not a death sentence. It’s not your destiny. I think the more I work with those who suffer, the more I am encouraged by how people change, their ability to change, and the ways we can help. Every day, I am more and more impressed.”Harvard staff writer Alvin Powell contributed to this report.
The S&P 500 and NASDAQ hit record highs the week of May 8, and the Dow closed over 21,000. The “Trump Bump” (as the run up in capital markets is called) remains in full force. In all, I believe the business environment will be more favorable under the Trump administration.Some factors make maintaining a favorable environment for business less likely, however. For example, the current run up is premature given we are still lacking specifics on many aspects of the new administration’s fiscal policy. In addition, predicting when the new administration’s fiscal measures (and in what final form) will be passed and become effective is problematic.Another concern for businesses in the current economic climate is the Federal Reserve’s rate-raising intentions. The decisions and narrative of the Federal Open Market Committee demonstrate a heavy bias toward employment measures at the expense of GDP, inflation, the nuances of employment (like participation rate), and even a full appreciation of the unique circumstances of rates near zero for seven years. Notably, the FOMC’s rate forecast has been widely off for five years in a row. In all, this doesn’t lend confidence that the Fed will make the right decision about interest rates during its remaining meetings in 2017. continue reading » 7SHARESShareShareSharePrintMailGooglePinterestDiggRedditStumbleuponDeliciousBufferTumblr
The BPIP bill arose amid controversies surrounding the deliberation of the HIP bill, which has received backlash from members of the public who questioned the timing of its deliberations as well as some of contentious articles in it.Read also: :Communist phobia sinks Pancasila bill at HouseOn Thursday, several Islamic groups, including the 212 Rally Alumni – a group formed from people who participated in the 2016 rally against then-Jakarta governor Basuki “Ahok” Tjahaja Purnama who faced prosecution for blasphemy – even hit the street outside the House compound to express their opposition to the HIP bill.Supported by the ruling Indonesian Democratic Party of Struggle (PDI-P), the HIP bill was initially intended to regulate the values of the Pancasila ideology and the functions of the BPIP, the steering committee head of which is the party’s chairwoman and former president Megawati Soekarnoputri.Activists, scholars and various groups have voiced opposition to the bill, with some prominent Islamic organizations in particular questioning the draft bill’s failure to include the 1966 TAP MPRS, which they feared could open the door for the reemergence of communist ideology in the country.The Indonesian Ulema Council (MUI) went as far as to deem the contents of the draft bill “secular and atheistic”, arguing that it degraded ideology of Pancasila itself.The government subsequently decided to halt deliberations of the HIP bill.Puan, who welcomed the ministers with the House deputy speakers on Thursday, said she expected the agreement between the House and the government on the BPIP bill to end all debate among the public about the HIP bill.”I hope that after this, all the controversies surrounding the HIP bill over the past few weeks will be over and we can work together in harmony to address the COVID-19 pandemic and its impacts,” the PDI-P politician added.Topics : The government submitted its newly proposed bill on the Agency for Pancasila Ideology Education (BPIP) to the House of Representatives on Thursday as both parties sought to end the controversies surrounding the much-criticized Pancasila Ideology Guidelines (HIP) bill.Coordinating Political, Legal and Security Affairs Minister Mahfud MD visited the house complex in Central Jakarta on Thursday and met with House of Representatives speaker Puan Maharani, during which they agreed to delay the deliberation of the HIP bill and move forward with the BPIP bill instead. Mahfud asserted that the BPIP bill was different from the controversial HIP bill, saying that the latter included the Temporary People’s Consultative Assembly Decree (TAP MPRS) No. 25/1966 on the banning of communism in Indonesia as one of its underlying foundations.”We also emphasize the Pancasila ideology that we officially use here in Chapter 1, Article 1 and Point 1 of the bill,” Mahfud said, before mentioning the five principles of Pancasila.Mahfud visited the House together with some of the top brass of the government, namely State Secretary Pratikno, Defense Minister Prabowo Subianto, Home Minister Tito Karnavian, Law and Human Rights Minister Yasonna Laoly and Administrative and Bureaucratic Reform Minister Tjahjo Kumolo. “We agree to be as transparent as possible so people can discuss and criticize the [BPIP] bill,” Mahfud said.
Each room in the home has cathedral ceilings.“It was quite a unique property and a bit of a sanctuary,” Mr Whitehouse said.“It needed a lot of work but we could see there was potential.” One of the bedrooms in the “secluded bungalow”.“It’s almost a bit of a secluded bungalow,” he said.“It’s very private, which is unusual and finding something like that in Holland Park is a bit of a rare gem.”Mr Whitehouse said the property would be suited to a number of buyers, from first homeowners like they were, to someone looking to expand the home or even a tradesman. The kitchen has had a renovation and there is a bench seat.The modern kitchen flows through to a dining room, which has a bench seat along louvred windows.The home is tucked away from the road and is on a 577sq m block. The bathroom has had a modern revamp.The couple got to work, replacing floors, fencing and the roof, as well as installing a new kitchen and bathroom.Outside they focused on creating an oasis, something Mr Whitehouse credits to his partner.More from newsCrowd expected as mega estate goes under the hammer7 Aug 2020Hard work, resourcefulness and $17k bring old Ipswich home back to life20 Apr 2020“I owe all that to Amanda, she’s the green thumb, not me,” Mr Whitehouse said.The residence opens to a large living space through double doors.The floors are polished timber, and the home has timber cathedral ceilings. The hidden urban oasis at 18 Sapphire St, Holland Park, is for sale.A HIDDEN sanctuary awaits behind the gate at 18 Sapphire St.Ed Whitehouse and Amanda Lusty bought the Holland Park property as their first home just over six years ago, and saw it as a project they hoped to turn into something special. Ms Lusty put blood, sweat and tears into creating the garden, her partner has said.“It’s got concrete pillars so it could easily be lifted and you could build a second story to accommodate families,” he said.“It’s also got dual access, so it would be easy for a tradesman to access with their trailer.”The couple are moving to be closer to their parents.Video Player is loading.Play VideoPlayNext playlist itemMuteCurrent Time 0:00/Duration 10:02Loaded: 0%Stream Type LIVESeek to live, currently playing liveLIVERemaining Time -10:02 Playback Rate1xChaptersChaptersDescriptionsdescriptions off, selectedCaptionscaptions settings, opens captions settings dialogcaptions off, selectedQuality Levels720p720pHD432p432p270p270p180p180pAutoA, selectedAudio Tracken (Main), selectedFullscreenThis is a modal window.Beginning of dialog window. Escape will cancel and close the window.TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaqueFont Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall CapsReset restore all settings to the default valuesDoneClose Modal DialogEnd of dialog window.This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.Close Modal DialogThis is a modal window. This modal can be closed by pressing the Escape key or activating the close button.PlayMuteCurrent Time 0:00/Duration 0:00Loaded: 0%Stream Type LIVESeek to live, currently playing liveLIVERemaining Time -0:00 Playback Rate1xFullscreenJune, 2018: Liz Tilley talks prestige property10:02
Senior Council Anthony W Astaphan.One of the essential points we were addressing on the Government in Focus program last night was the allegation that Roman Lakschin and the issues surrounding him began with the Honourable Prime Minister Mr. Roosevelt Skerrit. This allegation is plainly false. However, we said that a case concerning Mr. Laksckin was not filed in the International Court of Justice in 2006. This was inaccurate. But what was accurate, are the following;• the genesis of the appointment of Laksckin and the preparation for the case predated and preceded by many years the appointment of Mr. Roosevelt Skerrit as Prime Minister;• Mr. Roman Lakschin was first appointed as Deputy Permanent Representative and Ambassador to the United Nations Offices in Geneva by the Dominica Freedom Party prior to 1995;• He was appointed officially to the Post of Permanent Representative and Ambassador at the United Nations Offices in Geneva in March 1996;• As early as 2002 Mr. Lakschin sought to have proceedings instituted against Switzerland. • Mr. Lakschin’s intended application was fully supported in January 2002 by the former Prime Minister Mr. Edison James who swore to an affidavit in support of Mr. Lakschin;• An application was purportedly filed on behalf of the Government of Dominica in April 2006; and• The Prime Minister (less than a month later) by letter of 15th May 2006 informed the International Court of Justice that the application was to be promptly and unconditionally withdrawn. His Excellency Ambassador Vince Henderson. Image via: cadenagramonte.cuThe Honourable Prime Minister Roosevelt Skerrit informed the International Court of Justice that the Government of Dominica ‘did not wish to go on with the proceedings instituted against Switzerland’ and requested that the Court makes an Order ‘officially recording (the Government’s) unconditional discontinuance’. The Honourable Prime Minister also requested that the case be removed from the General List.We regret the error made during the program, but it is our view that the decisive and clear action on the part of the Honourable Mr.Roosevelt Skerrit establishes that he and the Cabinet of the Commonwealth of Dominica did not believe that it was in the public or country’s interest to pursue the matter against Switzerland and acted accordingly. Press Release Share LocalNews Statement on behalf of Ambassador Vince Henderson & Anthony W Astaphan, SC regarding Roman Lakschin by: – December 2, 2011 957 Views one comment Sharing is caring! Share Share Tweet
Newsroom GuidelinesNews TipsContact UsReport an Error He is recovering from a torn labrum that required surgery and cost him the 2015 season, and though it was his fifth rehab start this season, it was his second since his build-up was halted last month because of soreness.But his fastball, at least right now, is not what is was when he last pitched for the Dodgers in 2014. The four-seamer averaged 92 mph that season, according to PITCHf/x data tabulated by Brooks Baseball, and 91 mph when he debuted in 2013.Roberts said he hoped Ryu could at least. bring his fastball up to 88 mph before he is called up.“I think with his pitch ability and command, as long as he’s healthy, that’s more than serviceable,” Roberts said.Ryu is scheduled to make another start next week, building up to five innings and 65 pitches and is expected to make five more before returning to the rotation. LOS ANGELES >> On the one hand, Hyun-Jin Ryu came out of his minor league injury-rehabilitation start for Class-A Rancho Cucamonga earlier this weekend feeling fine.Ryu threw four scoreless innings Friday night, and Dodgers manager Dave Roberts reported a day later that the left-hander felt good.An eyebrow-raising moment, though, arrived when Roberts also revealed that Ryu’s fastball sat 86 mph and fell anywhere from 82-89 mph.“You want to get the average up a little bit higher,” Roberts said. “I know that it is rehab, but I expect the velocity to go up.” “The results, we don’t care about,” Roberts said. “I think that it’s more for us how the pitches are executed and how they feel afterward.”Maeda good to go It looked a little ominous at first, when Kenta Maeda was hit by a 95 mph line drive in his right leg Tuesday at Arizona.But Maeda will still make his next scheduled start on Sunday afternoon in the series finale against Milwaukee.“Tomorrow?” asked Roberts, as the Japanese rookie walked through the dugout during the manager’s pregame session with reporters.“Yes,” Maeda replied and pumped his fist.“There you go,” Roberts said, answering a question about Maeda’s status.The right-hander left his start against the Diamondbacks in the sixth inning, though X-rays were later revealed to be normal and indicated only a leg bruise.“Every day, it gets better,” Roberts said. “It shouldn’t affect him at all.”Maeda has not missed a start this season, but one was pushed back earlier this month because of soreness in his hand.Last hurdleYasiel Puig made his final rehab start for Class-A for Rancho Cucamonga on Saturday. He went 1 for 4 and struck out twice.He left after seven innings. Roberts had said he did not need to play an entire game.Puig, out with a strained left hamstring, is scheduled to be activated from the disabled list Monday, as the Dodgers host Washington for a three-game series.In his five minor-league rehab assignments, Puig was 5 for 16 with a home run and two RBI.To make room for Puig, the Dodgers can option one of their outfielders, Kiké Hernández, Scott Van Slyke and Will Venable.AlsoJoc Pederson hit leadoff for the first time this season, while Chase Utley had a scheduled day off. Pederson was in the leadoff spot 69 times as a rookie in 2015 and had a .216 batting average, a .325 on-base percentage and a .437 slugging percentage in those opportunities. “There’s been some better contact,” Roberts said.